This Article Full Text Full Text (PDF) All Versions of this Article: 52/6/1051    most recent HYPERTENSIONAHA.108.120352v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chirinos, J. A. Articles by Medina-Lezama, J. Search for Related Content PubMed PubMed Citation Articles by Chirinos, J. A. Articles by Medina-Lezama, J. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB (L)-ARGININE Medline Plus Health Information Carotid Artery Disease High Blood Pressure Related Collections Pathophysiology Risk Factors Other etiology Epidemiology Endothelium/vascular type/nitric oxide

(Hypertension. 2008;52:1051.)
© 2008 American Heart Association, Inc.

Original Articles

Endogenous Nitric Oxide Synthase Inhibitors, Arterial Hemodynamics, and Subclinical Vascular Disease

The PREVENCION Study

Julio A. Chirinos; Robert David; J. Alexander Bralley; Humberto Zea-Díaz; Edgar Muñoz-Atahualpa; Fernando Corrales-Medina; Carolina Cuba-Bustinza; Julio Chirinos-Pacheco; Josefina Medina-Lezama

From the University of Pennsylvania (J.A.C.), Philadelphia; Metametrix Clinical Laboratory (R.D., J.A.B.), Duluth, Ga; and Santa Maria Catholic University School of Medicine (H.Z-D., E.M-A., F.C-M., C.C-B., J.C-P., J.M-L.). AQP, Peru.

Correspondence to Julio A. Chirinos, Division of Cardiology, 8B111, Philadelphia VA Medical Center, 3900 Woodland Ave, Philadelphia, PA 19104. E-mail Julio.chirinos{at}uphs.upenn.edu

Endogenous NO synthase inhibitors (end-NOSIs) have been associated with cardiovascular risk factors and atherosclerosis. In addition, end-NOSIs may directly cause hypertension through hemodynamic effects. We aimed to examine the association between end-NOSI asymmetrical dimethylarginine (ADMA) and N-guanidino-monomethyl-arginine (NMMA), subclinical atherosclerosis, and arterial hemodynamics. We studied 922 adults participating in a population-based study (PREVENCION Study) and examined the correlation between end-NOSI/L-arginine and arterial hemodynamics, carotid-femoral pulse wave velocity, and carotid intima-media thickness using linear regression. ADMA, NMMA, and L-arginine were found to be differentially associated with various classic cardiovascular risk factors. ADMA and NMMA (but not L-arginine) were significant predictors of carotid intima-media thickness, even after adjustment for cardiovascular risk factors, C-reactive protein, and renal function. In contrast, ADMA and NMMA did not predict carotid-femoral pulse wave velocity, blood pressure, or hemodynamic abnormalities. Higher L-arginine independently predicted systolic hypertension, higher central pulse pressure, incident wave amplitude, central augmented pressure, and lower total arterial compliance but not systemic vascular resistance or cardiac output. We conclude that ADMA and NMMA are differentially associated with cardiovascular risk factors, but both end-NOSIs are independent predictors of carotid atherosclerosis. In contrast, they are not associated with large artery stiffness, hypertension, or hemodynamic abnormalities. Our findings are consistent with a role for asymmetrical arginine methylation in atherosclerosis but not in large artery stiffening, hypertension, or long-term hemodynamic regulation. L-Arginine is independently associated with abnormal pulsatile (but not resistive) arterial hemodynamic indices, which may reflect abnormal L-arginine transport, leading to decreased intracellular bioavailability for NO synthesis.

Key Words: asymmetrical dimethylarginine • hypertension • atherosclerosis • arterial stiffness • hemodynamics

This article has been cited by other articles:

				A. Pikula, R. H. Boger, A. S. Beiser, R. Maas, C. DeCarli, E. Schwedhelm, J. J. Himali, F. Schulze, R. Au, M. Kelly-Hayes, et al. Association of Plasma ADMA Levels With MRI Markers of Vascular Brain Injury: Framingham Offspring Study Stroke, September 1, 2009; 40(9): 2959 - 2964. [Abstract] [Full Text] [PDF]

				R. Maas, V. Xanthakis, J. F. Polak, E. Schwedhelm, L. M. Sullivan, R. Benndorf, F. Schulze, R. S. Vasan, P. A. Wolf, R. H. Boger, et al. Association of the Endogenous Nitric Oxide Synthase Inhibitor ADMA With Carotid Artery Intimal Media Thickness in the Framingham Heart Study Offspring Cohort Stroke, August 1, 2009; 40(8): 2715 - 2719. [Abstract] [Full Text] [PDF]